Cerebral Venous and Sinus Thrombosis and Thrombophilic Mutations in Western Iran: Association With Factor V Leiden

Abstract

The present study aimed at investigating the prevalence of factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T in cerebral venous and sinus thrombosis (CVST) patients and their possible association with CVST in Western Iran. A total of 24 CVST patients with the mean age of 37.1 ± 11.7 years and 100 sex- and age-matched healthy individuals from Kermanshah Province of Iran with ethnic background of Kurd were studied for factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T by PCR-RFLP method using Mnl I, Hind III, and Hinf I restriction enzymes, respectively. Prevalence of factor V Leiden was 16.7% in patients and 2% in control group. A significant association was found between factor V Leiden mutation and CVST with odds ratio (OR) of 9.8 (95% confidence intervals [CI] 1.68-57.2, P = .01). No prothrombin G20210A was found among patients. In patients, MTHFR C677T tended to be higher (58.3%) compared to control (44%), OR of 1.8 (95% CI 0.73-4.5, P = .2). Our study for the first time has determined the prevalence of inherited thrombophilia in a homogenous ethnic group of CVST patients and suggests that factor V Leiden, and not the prothrombin gene mutation is a risk factor for CVST in Western Iran.

Keywords

factor V Leiden prothrombin G20210A MTHFR C677T CVST Western Iran

References

Endler G. , Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta. 2003 ;330(1-2):31-55.

Poort SR , Rosendaal FR , Reitsma PH , Bertina RM A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698-3703.

Kimber J. Cerebral venous sinus thrombosis. Q J Med. 2002;95(3):137-142.

Saadatnia M. , Tajmirriahi M. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis. Acta Neurol Scand. 2007;115(5):295-300.

Otrock ZK , Taher AT , Shamseddeen WA , Mahfouz RA Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosis. J Thromb Thrombolysis. 2008;26(1):41-43.

Rahimi Z. , Vaisi-Raygani A. , Mozafari H. , Kharrazi H. , Rezaei M. , Nagel RL Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis . 2008;25(3):280-283.

Old JM , Higgs DR Gene analysis. In: Weatherall DJ, ed. Methods in Hemotology. The Thalassemias. Vol 6., London: Churchill Livingstone; 1983:74-101.

Bertina RM , Koeleman BPC , Koster T. , et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-67.

Frosst P. , Blom HJ , Milos R. , et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet . 1995;10(1):111-113.

10.

Dölek B. , Eraslan S. , Eroğlu S. , et al. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients . Clin Appl Thromb Hemost. 2007;13(4):435-438.

11.

Gadelha T. , Andre Ch , Juca AAV , Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis. 2005;19(1): 49-52.

12.

Ludemann P. , Nabavi D. , Junker R. , et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients . Stroke. 1998;29(12): 2507-2510.

13.

Lichy CH , Dong-Si T. , Reuner K. , et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol. 2006;253(3):316-320.

14.

Dentali F. , Crowther M. , Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006 ;107(7): 2766-2773.

15.

Buyru N. , Altinisik J. , Somay G. , Ulutin T. Factor V Leiden mutation in cerebrovascular disease. Clin Appl Thromb Hemost. 2005;11(3):339-342.

16.

Rodrigues CA , Rocha LKA , Morelli VM , Franco RF , Lourenco DM Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost . 2004;2(7):1211-1212.

17.

Bezemer ID , Doggen CJM , Vos HL , Rosendaal FR no association between the common MTHFR 677C→T polymorphism and venous thrombosis. Arch Intern Med. 2007;167(5):497-501.

18.

den Heijer M. , Koster T. , Blom HJ , et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996 ;334(12):759-762.

19.

Okumus G. , Kiyan E. , Arseven O. , et al. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost. 2008;14(2):168-73.

20.

Saadatnia M. , Mousavi SA , Haghighi S. , Aminorroaya A. Cerebral vein and sinus thrombosis in Isfahan-Iran: a changing profile. Can J Neurol Sci. 2004 ;31(4): 474-477.

21.

Janghorbani M. , Zare M. , Saadatnia M. , Mousavi SA , Mojarrad M. , Asgari E. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand. 2008;117(2): 117-121.